Skybiotech Healt

  • Market Cap: Micro Cap
  • Industry: Garments & Apparels
  • ISIN: INE393H01016
  • NSEID:
  • BSEID: 512036
INR
165.00
7.25 (4.6%)
BSENSE

Jun 04, 03:30 PM

BSE+NSE Vol: 5

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 364572,
    "name": "Skybiotech Healt",
    "stock_name": "Skybiotech Healt",
    "full_name": "Skybiotech Healthcare Limited",
    "name_url": "stocks-analysis/skybiotech-healt",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "165.00",
    "chg": 7.25,
    "chgp": "4.6%",
    "dir": 1,
    "prev_price": "157.75",
    "mcapval": "30.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 512036,
    "symbol": "",
    "ind_name": "Garments & Apparels",
    "ind_code": 67,
    "sector_id": 32,
    "indexname": "India SENSEX",
    "isin": "INE393H01016",
    "curr_date": "Jun 04, 03:30 PM",
    "curr_time": "18:24 PM",
    "last_traded_at": "Jun 04, 03:30 PM IST",
    "bse_nse_vol": "5 ",
    "exc_status": "Active",
    "traded_date": "Jun 04, 2026",
    "traded_date_str": "2026 06 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/skybiotech-healt-364572-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Skybiotech Healthcare Limited latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-skybiotech-healthcare-limited-latest-results-good-or-bad-4032493",
        "imagepath": "",
        "date": "2026-06-02 19:39:02",
        "description": "Skybiotech Healthcare Limited's latest financial results for Q4 FY26 present a mixed picture, highlighting both operational challenges and some signs of revenue recovery. The company reported net sales of ₹1.83 crores, which reflects a significant quarter-on-quarter increase of 90.63%. However, this growth comes after a previous decline, indicating volatility in revenue generation. Year-on-year, the revenue also shows a notable increase of 79.41% compared to ₹1.02 crores in Q4 FY25.\n\nDespite the revenue growth, the company's operational struggles are evident. Skybiotech recorded a net loss of ₹0.30 crores, which is a 37.50% decline from the previous quarter's loss. The operating margin remains deeply negative at -48.09%, suggesting ongoing difficulties in converting sales into profits. The company has now reported negative operating profits for seven consecutive quarters, indicating persistent operational d..."
      },
      {
        "title": "Skybiotech Healthcare Q4 FY26: Mounting Losses Signal Deepening Operational Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/skybiotech-healthcare-q4-fy26-mounting-losses-signal-deepening-operational-crisis-4028723",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SkybiotechHealt_quaterlyResult_4028723.png",
        "date": "2026-06-01 14:35:15",
        "description": "Skybiotech Healthcare Limited, a micro-cap textile manufacturer with a market capitalisation of ₹28.00 crores, reported a net loss of ₹0.30 crores for Q4 FY26, marking the seventh consecutive quarter of losses despite a sharp revenue uptick. The stock surged 5.00% on June 01, 2026, closing at ₹152.25, though this represents a 35.84% decline from its 52-week high of ₹237.30."
      },
      {
        "title": "Are Skybiotech Healthcare Limited latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-skybiotech-healthcare-limited-latest-results-good-or-bad-4023960",
        "imagepath": "",
        "date": "2026-05-30 19:54:23",
        "description": "Skybiotech Healthcare Limited's latest financial results for Q3 FY26 indicate significant operational challenges. The company reported net sales of ₹0.96 crores, reflecting a year-on-year decline of 61.90% from ₹2.52 crores in Q3 FY25, and a quarter-on-quarter contraction of 50.00% from ₹1.92 crores in Q2 FY26. This sharp revenue drop raises concerns about the company's ability to maintain sustainable client engagements or trading opportunities, especially given the previous quarter's decline of 19.67%.\n\nThe net loss for the quarter was ₹0.48 crores, which represents a worsening from the loss of ₹0.31 crores in the prior quarter. The operating margin also deteriorated significantly, standing at negative 45.83%, compared to negative 11.46% in Q2 FY26. This indicates that the company's core operations are incurring substantial losses, consuming capital at an accelerating rate.\n\nSkybiotech's return on equity (..."
      },
      {
        "title": "When is the next results date for Skybiotech Healthcare Limited?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-skybiotech-healthcare-limited-4017599",
        "imagepath": "",
        "date": "2026-05-27 23:17:59",
        "description": "The next results date for Skybiotech Healthcare Limited is scheduled for 30 May 2026...."
      },
      {
        "title": "Skybiotech Healthcare Limited is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/skybiotech-healthcare-limited-is-rated-strong-sell-3991079",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SkybiotechHealt_mojoScore_3991079.png",
        "date": "2026-05-14 10:10:32",
        "description": "Skybiotech Healthcare Limited is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Skybiotech Healthcare Limited is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/skybiotech-healthcare-limited-is-rated-strong-sell-3949143",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SkybiotechHealt_mojoScore_3949143.png",
        "date": "2026-04-16 10:10:16",
        "description": "Skybiotech Healthcare Limited is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Dec 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 187,
    "sid": "364572",
    "stock_news_url": "https://www.marketsmojo.com/news/skybiotech-healthcare-limited-364572"
  },
  "announcements": [
    {
      "caption": "Results Financials For The Year Ended On 31St March 2026",
      "datetime": "30-May-2026",
      "details": "Submission of Financial Results for the Quarter and Year ended on 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Submission Of Outcome Of Board Meeting And Submission Of Financial Results For The Quarter And Year Ended On 31St March 2026",
      "datetime": "30-May-2026",
      "details": "Submission of Outcome of board meeting and Financial Results for the quarter and year ended on 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Approval Of Audited Results For The Quarter And Year Ended On March 31 2026",
      "datetime": "26-May-2026",
      "details": "Skybiotech Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Approval of Audited Results for the Quarter and Year ended on March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Results Financials For The Year Ended On 31St March 2026

30-May-2026 | Source : BSE

Submission of Financial Results for the Quarter and Year ended on 31st March 2026

Board Meeting Outcome for Submission Of Outcome Of Board Meeting And Submission Of Financial Results For The Quarter And Year Ended On 31St March 2026

30-May-2026 | Source : BSE

Submission of Outcome of board meeting and Financial Results for the quarter and year ended on 31st March 2026

Board Meeting Intimation for Approval Of Audited Results For The Quarter And Year Ended On March 31 2026

26-May-2026 | Source : BSE

Skybiotech Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Approval of Audited Results for the Quarter and Year ended on March 31 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available